These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8658509)

  • 1. Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD.
    Portier CJ; Sherman CD; Kohn M; Edler L; Kopp-Schneider A; Maronpot RM; Lucier G
    Toxicol Appl Pharmacol; 1996 May; 138(1):20-30. PubMed ID: 8658509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
    Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats.
    Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ
    Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
    Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
    Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
    Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC
    Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
    Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
    Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter.
    Conolly RB; Andersen ME
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):281-93. PubMed ID: 9344896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: A quantitative analysis of experimental data using a stochastic model.
    Luebeck EG; Buchmann A; Stinchcombe S; Moolgavkar SH; Schwarz M
    Toxicol Appl Pharmacol; 2000 Aug; 167(1):63-73. PubMed ID: 10936080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints.
    Maronpot RR; Foley JF; Takahashi K; Goldsworthy T; Clark G; Tritscher A; Portier C; Lucier G
    Environ Health Perspect; 1993 Dec; 101(7):634-42. PubMed ID: 8143597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
    Moolgavkar SH; Luebeck EG; Buchmann A; Bock KW
    Toxicol Appl Pharmacol; 1996 May; 138(1):31-42. PubMed ID: 8658510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of hepatic 8-oxo-deoxyguanosine adducts by 2,3,7,8-tetrachlorodibenzo-p-dioxin in Sprague-Dawley rats is female-specific and estrogen-dependent.
    Wyde ME; Wong VA; Kim AH; Lucier GW; Walker NJ
    Chem Res Toxicol; 2001 Jul; 14(7):849-55. PubMed ID: 11453731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat.
    Dragan YP; Xu XH; Goldsworthy TL; Campbell HA; Maronpot RR; Pitot HC
    Carcinogenesis; 1992 Aug; 13(8):1389-95. PubMed ID: 1354083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
    Schrenk D; Buchmann A; Dietz K; Lipp HP; Brunner H; Sirma H; Münzel P; Hagenmaier H; Gebhardt R; Bock KW
    Carcinogenesis; 1994 Mar; 15(3):509-15. PubMed ID: 8118936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Tritscher AM; Mahler J; Portier CJ; Lucier GW; Walker NJ
    Toxicol Pathol; 2000; 28(6):761-9. PubMed ID: 11127289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
    Pitot HC; Goldsworthy T; Campbell HA; Poland A
    Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced tumor promotion by 17 beta-estradiol in female Sprague--Dawley rats.
    Wyde ME; Eldridge SR; Lucier GW; Walker NJ
    Toxicol Appl Pharmacol; 2001 May; 173(1):7-17. PubMed ID: 11350210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of preneoplastic altered hepatic foci following dietary sulphur supplementation.
    Arora A; Shukla Y
    Hum Exp Toxicol; 2004 May; 23(5):229-34. PubMed ID: 15222400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of altered hepatic foci by a mixture of dioxin-like compounds with and without 2,2',4,4',5,5'-hexachlorobiphenyl in female Sprague-Dawley rats.
    van der Plas SA; Haag-Grönlund M; Scheu G; Wärngård L; van den Berg M; Wester P; Koeman JH; Brouwer A
    Toxicol Appl Pharmacol; 1999 Apr; 156(1):30-9. PubMed ID: 10101096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains.
    Viluksela M; Bager Y; Tuomisto JT; Scheu G; Unkila M; Pohjanvirta R; Flodström S; Kosma VM; Mäki-Paakkanen J; Vartiainen T; Klimm C; Schramm KW; Wärngård L; Tuomisto J
    Cancer Res; 2000 Dec; 60(24):6911-20. PubMed ID: 11156390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.